Valeria Marino, medical director of Pfizer Italy claims to have to abide by the scientific studies currently available
ROME – «The vaccine was studied for a second administration at 21 days. Data on a longer range of administration at the moment we do not have any except in real life observations, as has been done in the UK. It is an evaluation by the CTS, we will observe what happens. Like Pfizer, however, I say to stick to what emerged from the studies
scientific because this guarantees the results that allowed the authorization ». Valeria Marino, medical director of Pfizer Italia, told Sky TG24, commenting on the extension to 5 weeks of the window for the administration of the second dose.
COPYRIGHT today © breaking latest news